NCT00388258View on ClinicalTrials.gov

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

PHASE3CompletedINTERVENTIONAL

Enrollment

451

Participants

Timeline

Start Date

March 1, 2001

Primary Completion Date

December 1, 2002

Study Completion Date

December 1, 2002

Conditions

Ileus

Interventions

DRUG

Alvimopan

Trial Locations (1)

19341

Various, Exton

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY